NO976142L - Anvendelse av minst en NO syntase inhibitor i behandling av f÷lsom hud - Google Patents

Anvendelse av minst en NO syntase inhibitor i behandling av f÷lsom hud

Info

Publication number
NO976142L
NO976142L NO976142A NO976142A NO976142L NO 976142 L NO976142 L NO 976142L NO 976142 A NO976142 A NO 976142A NO 976142 A NO976142 A NO 976142A NO 976142 L NO976142 L NO 976142L
Authority
NO
Norway
Prior art keywords
sensitive skin
synthase inhibitor
treatment
symptoms associated
treat
Prior art date
Application number
NO976142A
Other languages
English (en)
Other versions
NO976142D0 (no
NO312272B1 (no
Inventor
Lionel Breton
Olivier De Lacharriere
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9483954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO976142(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Publication of NO976142D0 publication Critical patent/NO976142D0/no
Publication of NO976142L publication Critical patent/NO976142L/no
Publication of NO312272B1 publication Critical patent/NO312272B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19976142A 1995-10-26 1997-12-30 Anvendelse av minst en NO syntase inhibitor i behandling av fölsom hud NO312272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512653A FR2740339B1 (fr) 1995-10-26 1995-10-26 Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
PCT/FR1996/001529 WO1997015280A1 (fr) 1995-10-26 1996-10-01 Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles

Publications (3)

Publication Number Publication Date
NO976142D0 NO976142D0 (no) 1997-12-30
NO976142L true NO976142L (no) 1998-06-03
NO312272B1 NO312272B1 (no) 2002-04-22

Family

ID=9483954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19976142A NO312272B1 (no) 1995-10-26 1997-12-30 Anvendelse av minst en NO syntase inhibitor i behandling av fölsom hud

Country Status (9)

Country Link
US (1) US20020037854A1 (no)
EP (1) EP0859591B1 (no)
JP (1) JP3110050B2 (no)
AT (1) ATE247454T1 (no)
CA (1) CA2222303C (no)
DE (1) DE69629578D1 (no)
FR (1) FR2740339B1 (no)
NO (1) NO312272B1 (no)
WO (1) WO1997015280A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036730A2 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die behandlung von rosacea
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
FR2778562B1 (fr) * 1998-05-14 2000-08-04 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
GR1003146B (el) * 1998-06-23 1999-06-02 Μεθοδος εξουδετερωσης των πολεμικων χημικων αεριων της μουσταρδας, της σαρινης και του δερματικου ερυθηματος απο την υπεριωδη ακτινοβολια του ηλιου με την χρησιμοποιηση αναστολεων των ελευθερων ριζων
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
DE19945484A1 (de) * 1999-09-22 2001-04-05 Kolb Bachofen Victoria NO-freisetzende topisch applizierbare Zusammensetzung
DE19962267A1 (de) * 1999-12-23 2001-06-28 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren NO-Synthasehemmern und einer oder mehreren Ascorbylverbindungen zur Stärkung der Barrierefunktion der Haut
DE10000840A1 (de) * 2000-01-12 2001-07-19 Beiersdorf Ag Verwendung eines oder mehrerer NO-Synthasehemmer
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
FR2808189B1 (fr) * 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
FR2808190B1 (fr) * 2000-04-28 2002-06-21 Oreal Extrait de vegetal de l'espece vitis vinifera comme inhibiteur de no-synthase et utilisations
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
DE10047204A1 (de) * 2000-09-23 2002-04-25 Henkel Kgaa Topische Hautbehandlungsmittel mit Arginase
FR2818136B1 (fr) * 2000-12-15 2004-10-15 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un inhibiteur de no-synthase
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
DE10111052A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
DE10111054A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
FR2825923B1 (fr) * 2001-06-15 2006-04-07 Oreal Inhibiteur de no-synthase et utilisations
FR2825920B1 (fr) * 2001-06-15 2006-04-28 Oreal Desferal comme inhibiteur de no-synthase et utilisations
FR2825921B1 (fr) * 2001-06-15 2005-02-11 Oreal Inhibiteur de no-synthase et utilisations
CA2456035A1 (fr) * 2003-02-03 2004-08-03 L'oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
FR2850578B1 (fr) * 2003-02-03 2006-07-28 Oreal Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
JP5376761B2 (ja) * 2004-02-23 2013-12-25 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 身体の外観および皮膚の外観を改善するための、一酸化窒素の局所送達
WO2005102282A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
CA2608457C (en) 2005-05-17 2013-09-10 Santen Pharmaceutical Co., Ltd. Ebselen as a prophylactic or therapeutic agent for corneal or conjunctival disorders
EP1749528A1 (en) * 2005-08-05 2007-02-07 Pharma C S.A. Pharmaceutical combinations containing a mu opioid agonist and an inhibitor of NO production
EP2163548B1 (en) * 2007-05-25 2011-08-10 Santen Pharmaceutical Co., Ltd Prophylactic or therapeutic agent for age-related macular degeneration
WO2009107759A1 (ja) * 2008-02-28 2009-09-03 参天製薬株式会社 視神経障害を伴う眼疾患の予防又は治療剤
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP3045171A1 (en) 2009-06-24 2016-07-20 Strategic Science & Technologies, LLC Topical composition
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
WO2017139457A1 (en) * 2016-02-11 2017-08-17 Ohio University Compositions and methods for inhibiting uvb -irradiation damage by targeting constitutive nitric oxide synthases (cnos)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096521A3 (en) * 1982-06-01 1985-01-23 THE PROCTER & GAMBLE COMPANY Depilatory compositions
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
AU1209995A (en) * 1993-11-17 1995-06-06 Duke University Medical Center Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
AU692892B2 (en) * 1994-06-15 1998-06-18 Wellcome Foundation Limited, The Enzyme inhibitors

Also Published As

Publication number Publication date
FR2740339B1 (fr) 1997-12-05
ATE247454T1 (de) 2003-09-15
NO976142D0 (no) 1997-12-30
US20020037854A1 (en) 2002-03-28
EP0859591B1 (fr) 2003-08-20
CA2222303C (fr) 2003-01-14
FR2740339A1 (fr) 1997-04-30
WO1997015280A1 (fr) 1997-05-01
EP0859591A1 (fr) 1998-08-26
NO312272B1 (no) 2002-04-22
DE69629578D1 (de) 2003-09-25
CA2222303A1 (fr) 1997-05-01
JPH10511404A (ja) 1998-11-04
JP3110050B2 (ja) 2000-11-20

Similar Documents

Publication Publication Date Title
NO976142L (no) Anvendelse av minst en NO syntase inhibitor i behandling av f÷lsom hud
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
NO973900D0 (no) Nitrogenoksyd syntase inhibitorer
TR199901173T2 (xx) Canl�larda glutamat anormalli�inin tedavisi ve n�ronal aktivitenin d�zenlenmesi i�in y�ntemler ve NAALADase bile�imleri.
DE69435270D1 (de) Verwendung der neurotoxischen Komponente von Botulinum Toxin zur Behandlung spastischer Muskeln
ATE298566T1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
DK0946166T3 (da) Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
DE69632632D1 (de) Behandlungsverfahren für darmadenome
MX9805290A (es) Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta.
DE69327248D1 (de) Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
ATE239467T1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
BR0016415A (pt) Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico
BR9917113A (pt) Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e uso
NO982582L (no) Fremgangsmaate for behandling av smerte
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
BR9612552A (pt) Processo para tratamento de autismo
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
NO984198L (no) FremgangsmÕte for behandling av aggresjon
HUP9903979A3 (en) Use of nitric oxidesynthase inhibitors to treat or prevent type ii diabetes
SE9301606D0 (sv) Composition for the treatment of impaired hair growth
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
ATE213644T1 (de) Kombinationstherapie für die behandlung von arthritis erkrankungen
NO984190L (no) FremgangsmÕte for behandling av insomnia